De Leo V - Search Results

1

Polycystic ovary syndrome and metabolic comorbidities: therapeutic options.

De Leo V, Musacchio MC, Palermo V, Di Sabatino A, Morgante G, Petraglia F. De Leo V, et al. Drugs Today (Barc). 2009 Oct;45(10):763-75. Drugs Today (Barc). 2009. PMID: 20069140 Review.

2

Insulin-lowering treatment reduces aromatase activity in response to follicle-stimulating hormone in women with polycystic ovary syndrome.

la Marca A, Morgante G, Palumbo M, Cianci A, Petraglia F, De Leo V. la Marca A, et al. Among authors: de leo v. Fertil Steril. 2002 Dec;78(6):1234-9. doi: 10.1016/s0015-0282(02)04346-7. Fertil Steril. 2002. PMID: 12477517 Free article.

3

Insulin-lowering agents in the management of polycystic ovary syndrome.

De Leo V, la Marca A, Petraglia F. De Leo V, et al. Endocr Rev. 2003 Oct;24(5):633-67. doi: 10.1210/er.2002-0015. Endocr Rev. 2003. PMID: 14570747 Review.

4

Metformin treatment is effective in obese teenage girls with PCOS.

De Leo V, Musacchio MC, Morgante G, Piomboni P, Petraglia F. De Leo V, et al. Hum Reprod. 2006 Sep;21(9):2252-6. doi: 10.1093/humrep/del185. Epub 2006 Jun 19. Hum Reprod. 2006. PMID: 16785260 Clinical Trial.

5

Evaluation of effects of an oral contraceptive containing ethinylestradiol combined with drospirenone on adrenal steroidogenesis in hyperandrogenic women with polycystic ovary syndrome.

De Leo V, Morgante G, Piomboni P, Musacchio MC, Petraglia F, Cianci A. De Leo V, et al. Fertil Steril. 2007 Jul;88(1):113-7. doi: 10.1016/j.fertnstert.2006.11.137. Epub 2007 Apr 6. Fertil Steril. 2007. PMID: 17418832 Free article.

6

Effect of oral contraceptives on markers of hyperandrogenism and SHBG in women with polycystic ovary syndrome.

De Leo V, Di Sabatino A, Musacchio MC, Morgante G, Scolaro V, Cianci A, Petraglia F. De Leo V, et al. Contraception. 2010 Sep;82(3):276-80. doi: 10.1016/j.contraception.2010.04.002. Epub 2010 Jul 16. Contraception. 2010. PMID: 20705157 Clinical Trial.

7

Metformin improves semen characteristics of oligo-terato-asthenozoospermic men with metabolic syndrome.

Morgante G, Tosti C, Orvieto R, Musacchio MC, Piomboni P, De Leo V. Morgante G, et al. Among authors: de leo v. Fertil Steril. 2011 May;95(6):2150-2. doi: 10.1016/j.fertnstert.2010.12.009. Epub 2010 Dec 30. Fertil Steril. 2011. PMID: 21194687 Clinical Trial.

8

The role of inositol supplementation in patients with polycystic ovary syndrome, with insulin resistance, undergoing the low-dose gonadotropin ovulation induction regimen.

Morgante G, Orvieto R, Di Sabatino A, Musacchio MC, De Leo V. Morgante G, et al. Among authors: de leo v. Fertil Steril. 2011 Jun 30;95(8):2642-4. doi: 10.1016/j.fertnstert.2011.01.035. Epub 2011 Feb 5. Fertil Steril. 2011. PMID: 21300338 Free article.

9

Alterations in thyroid function among the different polycystic ovary syndrome phenotypes.

Morgante G, Musacchio MC, Orvieto R, Massaro MG, De Leo V. Morgante G, et al. Among authors: de leo v. Gynecol Endocrinol. 2013 Nov;29(11):967-9. doi: 10.3109/09513590.2013.829445. Epub 2013 Aug 19. Gynecol Endocrinol. 2013. PMID: 23957782 Free article.

10

Effects of metformin on gonadotropin-induced ovulation in women with polycystic ovary syndrome.

De Leo V, la Marca A, Ditto A, Morgante G, Cianci A. De Leo V, et al. Fertil Steril. 1999 Aug;72(2):282-5. doi: 10.1016/s0015-0282(99)00208-3. Fertil Steril. 1999. PMID: 10438996 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

465 results

Search Page

Filters